Development and multinational validation of a multiple myeloma-specific comorbidity index using real-world cohorts: CAREMM-2108.
Saved in:
| Title: | Development and multinational validation of a multiple myeloma-specific comorbidity index using real-world cohorts: CAREMM-2108. |
|---|---|
| Authors: | Choi S; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of data science, PIPET, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Byun JM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Oh SE; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Han J; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of data science, PIPET, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Jung S; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of data science, PIPET, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Han S; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of data science, PIPET, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Shin SH; Catholic Research Network for Multiple Myeloma, Seoul, Republic of Korea.; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, South Korea.; Department of Hematology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Yahng SA; Catholic Research Network for Multiple Myeloma, Seoul, Republic of Korea.; Department of Hematology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea., Jeon YW; Catholic Research Network for Multiple Myeloma, Seoul, Republic of Korea.; Department of Hematology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Li J; Alfred Hospital, Melbourne, VIC, Australia., Park SS; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. sspark@catholic.ac.kr.; Catholic Research Network for Multiple Myeloma, Seoul, Republic of Korea. sspark@catholic.ac.kr.; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, South Korea. sspark@catholic.ac.kr., Suzuki K; Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. kaz-suzuki@jikei.ac.jp., Min CK; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Catholic Research Network for Multiple Myeloma, Seoul, Republic of Korea.; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, South Korea. |
| Corporate Authors: | Catholic Research Network for Multiple Myeloma |
| Source: | Blood cancer journal [Blood Cancer J] 2026 Mar 31; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 31. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-026-01475-1 |
